Buy Tirzepatide Starter Kit in Australia
Buy the Tirzepatide starter kit in Australia from Macropus Peptides: one 20mg vial of research-grade Tirzepatide as lyophilised powder, a 3 mL vial of bacteriostatic water, ten 0.5 mL insulin syringes and twenty alcohol swabs. Tirzepatide is a 39 amino acid peptide that activates both the GIP and GLP-1 receptors, carrying a fatty diacid chain that binds albumin. The 20mg fill is our priced strength, and the kit costs less than the vial, water, syringe pack and swab pack ordered as separate lines. Each vial is labelled with its lot number, and the certificate of analysis for that lot is available on request. Order online and the kit is dispatched from Australian stock to every Australian state and territory. This is research material only, sold to adults for in-vitro laboratory work, not for human or veterinary use.
| Kit | Tirzepatide starter kit |
|---|---|
| Amount | starter kit |
| Form | Research kit |
| Contents | Tirzepatide 20mg vial, BAC water 3 mL, 10 × 0.5 mL insulin syringes and 20 alcohol swabs |
| Category | Kits, stacks and value packs |
| Storage | See label |
| Testing | HPLC purity 98% or higher and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
Buy Tirzepatide Starter Kit Australia: 20mg Vial and Supplies
Twenty milligrams is a large fill for an incretin peptide, and it makes a strong stock in a small volume. The kit pairs that vial with a 3 mL diluent and handling supplies so the first reconstitution needs nothing else. Macropus Peptides dispatches every carton from Australian stock, and the lot on the vial matches our stand-alone 20mg listing.
Tirzepatide: the dual incretin agonist in this kit
The gut releases two incretin hormones after a meal, GIP and GLP-1, which act on separate receptors to raise insulin release when glucose is high. Tirzepatide is a single 39 residue peptide, built mainly on the GIP sequence, that activates both. It includes non-natural amino acids, including aminoisobutyric acid at positions 2 and 13, to resist enzymatic breakdown, and a C20 fatty diacid chain that binds albumin, which extends its half-life to about five days. In the kit it arrives as lyophilised powder beside the diluent, syringes and swabs.
How Tirzepatide works in research
The two receptor actions are not equal. At the GIP receptor the molecule behaves much like native GIP, while at the GLP-1 receptor it binds more weakly and favours cyclic AMP signalling over the recruitment of beta-arrestin, a pattern described as imbalanced and biased agonism. That profile is part of why laboratories study it rather than simply combining two separate agonists. In cell lines expressing one or both receptors, and in rodent models, it is used to compare dual agonism with GLP-1 agonism alone and with triple agonists that add the glucagon receptor, and to examine how receptor internalisation differs between them.
Tirzepatide research record
Its discovery and first clinical data, under the code LY3298176, were published in Molecular Metabolism in 2018, and The Lancet carried its first multi-strength study in adults with type 2 diabetes that same year. A 2020 paper in JCI Insight described the imbalanced and biased receptor pharmacology. The New England Journal of Medicine then reported a head-to-head trial against a GLP-1 agonist in type 2 diabetes in 2021, and a 72-week trial in adults with obesity in 2022 that measured body weight change. Summaries sit in our Tirzepatide research studies library.
Tirzepatide kit specifications per order
| Specification | Detail |
|---|---|
| Kit | Tirzepatide starter kit |
| Amount | starter kit |
| Form | Research kit |
| Contents | Tirzepatide 20mg vial, BAC water 3 mL, 10 × 0.5 mL insulin syringes and 20 alcohol swabs |
| Category | Kits, stacks and value packs |
| Storage | See label |
- 20mg Tirzepatide as freeze-dried powder, lot and freezer temperature printed on the vial
- 3 mL of bacteriostatic water
- 10 insulin syringes, 0.5 mL capacity
- 20 alcohol swabs
Tirzepatide price: kit compared with the parts
| Option | Price |
|---|---|
| Tirzepatide starter kit | $262.99 |
Ordered loose, the 20mg vial, a 3 mL water bottle, the boxed syringes and the swab tub of one hundred, the incretin bill runs well past this kit. Dual agonist plus diluent on their own already match the kit price almost to the cent, so syringes and swabs arrive at no real cost. For larger programmes, the 40mg vial carries a much lower cost per milligram.
The Tirzepatide 20mg vial
Twenty milligrams is our entry strength for the dual agonist. It suits a protocol that must be set up and checked on one lot before moving to the 40mg size. Lipidated peptides are stable dry, so hold the vial at -20 °C inside its carton until mixing day.
Water and syringes in the Tirzepatide kit
The 3 mL preserved water bottle covers one full reconstitution at the usual strengths. With a stock this concentrated, the fine scale on the half-millilitre syringes matters: fifty marks of 0.01 mL each. The swabs clean the stopper before every entry, and all three items live at room temperature.
Best place to buy Tirzepatide Australia
- Sold online at macropuspeptides.com, priced at $262.99
- Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
- A certificate of analysis for every lot, matched to the lot number printed on the label
- Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
- Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
- Payment by PayID or bank transfer, with your order ID as the reference
How to order the Tirzepatide kit online
- Open the 20mg starter kit
- Choose how many to order
- Add the 40mg vial if scaling up
- Confirm adult research use at checkout
- Request the certificate for your lot
Reconstituting Tirzepatide 20mg
Two millilitres of water makes 10 mg per mL. A 2.5 mL volume makes 8 mg per mL, and the whole 3 mL makes about 6.67 mg per mL. At 10 mg per mL each single mark on the syringe carries 100 micrograms, so volumes are logged to the hundredth of a millilitre. Roll the vial gently; lipidated peptides can foam if shaken. Once dissolved, keep the dual agonist refrigerated (2 to 8 °C) and never refreeze the stock. Additional bacteriostatic water 10mL can go in the same parcel.
Is Tirzepatide available in Australia
Finished medicines containing it are entered on the ARTG by their sponsor and sit in Schedule 4 of the Poisons Standard. Our 20mg vial is none of those: it is unregistered laboratory material, supplied for in-vitro work alone; people and animals are outside its scope.
Tirzepatide for sale Australia wide
Kits of the dual agonist leave our Australian shelves for Hobart, Darwin, Canberra and rural postcodes alike. The single 20mg vial listing covers both strengths. Metabolic groups weigh it against the triple agonist in the Retatrutide starter kit or the amylin analogue in the Cagrilintide starter kit, or browse kits and stacks.
References
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Molecular Metabolism. 2018.
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. 2021.
- Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.